90 related articles for article (PubMed ID: 22265942)
1. [Focus on granulocyte colony-stimulating factor-induced pulmonary toxicity].
Noël-Savina E; Descourt R
Bull Cancer; 2012 Feb; 99(2):211-7. PubMed ID: 22265942
[TBL] [Abstract][Full Text] [Related]
2. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
Tigue CC; McKoy JM; Evens AM; Trifilio SM; Tallman MS; Bennett CL
Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
[TBL] [Abstract][Full Text] [Related]
4. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
[TBL] [Abstract][Full Text] [Related]
5. [A case report of interstitial pneumonia caused by granulocyte colony-stimulating factor].
Ibayashi Y; Ohyama H; Hashimoto Y; Sakatani K; Morimoto S; Takahashi H; Shibata K; Kashiwabara S; Tanabe S; Hashi K
No Shinkei Geka; 1994 Feb; 22(2):169-74. PubMed ID: 7509462
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
Ozkaynak MF; Krailo M; Chen Z; Feusner J
Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
[TBL] [Abstract][Full Text] [Related]
7. [Growth factors in oncology: effectiveness and prospects].
Ottmann OG; Hoelzer D
Praxis (Bern 1994); 1998 Sep; 87(36):1153-9. PubMed ID: 9782744
[TBL] [Abstract][Full Text] [Related]
8. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
[TBL] [Abstract][Full Text] [Related]
9. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
10. Review of granulocyte colony-stimulating factors in the treatment of established febrile neutropenia.
Pérez Velasco R
J Oncol Pharm Pract; 2011 Sep; 17(3):225-32. PubMed ID: 20562168
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor administration: adverse events.
D'Souza A; Jaiyesimi I; Trainor L; Venuturumili P
Transfus Med Rev; 2008 Oct; 22(4):280-90. PubMed ID: 18848155
[TBL] [Abstract][Full Text] [Related]
12. Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in neutropenia related with primary diseases.
Kavgaci H; Ozdemir F; Aydin F; Yavuz A; Yavuz M
J Exp Clin Cancer Res; 2002 Dec; 21(4):475-9. PubMed ID: 12636092
[TBL] [Abstract][Full Text] [Related]
13. [Recombinant human granulocyte colony-stimulating factor (G-CSF)].
Ariyoshi Y
Gan To Kagaku Ryoho; 1993 Mar; 20(4):541-9. PubMed ID: 7680849
[TBL] [Abstract][Full Text] [Related]
14. Exacerbation by granulocyte colony-stimulating factor of prior acute lung injury: implication of neutrophils.
Azoulay E; Attalah H; Yang K; Jouault H; Schlemmer B; Brun-Buisson C; Brochard L; Harf A; Delclaux C
Crit Care Med; 2002 Sep; 30(9):2115-22. PubMed ID: 12352050
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic growth factors in the reduction of chemotherapeutic toxicity.
Johnston EM; Crawford J
Semin Oncol; 1998 Oct; 25(5):552-61. PubMed ID: 9783594
[TBL] [Abstract][Full Text] [Related]
16. [Filgrastim--a hematopoietic growth factor (r-metHuC-CSF) for treatment of neutropenia caused by cytostatics].
Ersbøll J
Ugeskr Laeger; 1991 Sep; 153(38):2647-50. PubMed ID: 1719682
[No Abstract] [Full Text] [Related]
17. Additive effects of infection and neutropenia on the induction of granulocytopoietic activity in vivo.
Bönig HB; Hannen M; Lex C; Wölfel S; Banning U; Nürnberger W; Körholz D; Göbel U
Cancer; 1999 Jul; 86(2):340-8. PubMed ID: 10421271
[TBL] [Abstract][Full Text] [Related]
18. Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors.
Danova M; Barni S; Del Mastro L; Danesi R; Pappagallo GL
Expert Rev Anticancer Ther; 2011 Aug; 11(8):1303-13. PubMed ID: 21916584
[TBL] [Abstract][Full Text] [Related]
19. Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administration.
Higa GM; DeVore RF; Auber ML; Lynch JP; Landreth KS
Pharmacotherapy; 1998; 18(1):1-8. PubMed ID: 9469674
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
